Rui Ma

Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial

Luis Paz‐Ares, Mikhail Dvorkin, Yuanbin Chen et al. · The Lancet · 2019 · 2.2K citations

Medicine, Oncology, Pharmacology +14

Durvalumab, with or without tremelimumab, plus platinum–etoposide versus platinum–etoposide alone in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): updated results from a randomised, controlled, open-label, phase 3 trial

Jonathan W. Goldman, Mikhail Dvorkin, Yuanbin Chen et al. · The Lancet Oncology · 2020 · 687 citations · Full text

Medicine, Oncology, Pharmacology +14

UV Filters with Antagonistic Action at Androgen Receptors in the MDA-kb2 Cell Transcriptional-Activation Assay

Rui Ma · Toxicological Sciences · 2003 · 200 citations · Full text

Medicine, Endocrinology, Pharmacology +17

Comparative characterization of mesenchymal stem cells from human dental pulp and adipose tissue for bone regeneration potential

Qiaoqiao Jin, Keyong Yuan, Wen-Zhen Lin et al. · Artificial Cells Nanomedicine and Biotechnology · 2019 · 178 citations · Full text

Engineering, Bioengineering, Oral Biology +17

The decapeptide CMS001 enhances swimming endurance in mice

Huali Zhang, Rong Lu, Yanjiao Zhou et al. · Peptides · 2008 · 131 citations

Life Sciences, Physiology, Sports Medicine +12